A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients

Canadian Journal of Gastroenterology and Hepatology

Volumn 2018, Issue , 2018, Pages

  Shogbesan, Oluwaseun ^a   Poudel, Dilli Ram ^a   Victor, Samjeris ^b   Jehangir, Asad ^a   Fadahunsi, Opeyemi ^c   Shogbesan, Gbenga ^d   Donato, Anthony ^a  

^a Western Kentucky Heart and Lung Med Center Health Research Foundation and Tower Health Medical Group Cardiology West Reading   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d Athens Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL (TOPIC); CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COLONOSCOPY; DEATH; DIARRHEA; DIVERTICULITIS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; LEUKEMIA; LYMPHOMA; MALE; META ANALYSIS; NAUSEA; PATIENT HISTORY OF STEM CELL TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SECONDARY INFECTION; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTION; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; TREATMENT OUTCOME;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLONOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FECES; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIOTA; TREATMENT OUTCOME;

EID: 85053702733     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2018/1394379     Document Type: Review

References (61)

1. F. C. Lessa, L. G.Winston, and L. C. McDonald, "Emerging infections program C. difficile surveillance team. Burden of Clostridium difficile infection in the United States," The New England Journal of Medicine, vol. 372, pp. 2369-2370, 2015.
2. E.M.Drozd, T. J. Inocencio, S. Braithwaite et al., "Mortality, hospital costs, payments, and readmissions associated with clostridium difficile infection among medicare beneficiaries," Infectious Diseases in Clinical Practice, vol. 23, no. 6, pp. 318-323, 2015.
3. M. Kamboj, C. Son, S. Cantu et al., "Hospital-onset clostridium difficile infection rates in personswith cancer orHematopoietic stem cell transplant: A C3IC network report," Infection Control and Hospital Epidemiology, vol. 33, no. 11, pp. 1162-1164, 2012.
4. C. D. Alonso and M. Kamboj, "Clostridium difficile infection (CDI) in solid organ and hematopoietic stem cell transplant recipients," Current Infectious Disease Reports, vol. 16, p. 414, 2014.
5. S. Raza, M. A. Baig, H. Russell, Y. Gourdet, and B. J. Berger, "Clostridium difficile infection following chemotherapy," Recent Patents on Anti-Infective Drug Discovery, vol. 5, no. 1, pp. 1-9, 2010.
6. S. Schneeweiss, J. Korzenik,D. H. Solomon, C. Canning, J. Lee, and B. Bressler, "Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections," Alimentary Pharmacology &Therapeutics, vol. 30, no. 3, pp. 253-264, 2009.
7. C. P. Kelly and J. T. LaMont, "Clostridiumdifficile-more difficult than ever,"The New England Journal of Medicine, vol. 359, no. 18, pp. 1932-1940, 2008.
8. L. V.McFarland, G.W. Elmer, andC.M. Surawicz, "Breaking the cycle: Treatment strategies for 163 cases of recurrent Clostridiumdifficile disease," American Journal of Gastroenterology, vol. 97, no. 7, pp. 1769-1775, 2002.
9. E. vanNood,A.Vrieze, andM. Nieuwdorp, "Duodenal infusion of donor feces for recurrent clostridium difficile," The New England Journal of Medicine, vol. 368, no. 5, pp. 407-415, 2013.
10. G. Cammarota, L.Masucci,G. Ianiro et al., " Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent ," Alimentary Pharmacology &Therapeutics, vol. 41, no. 9, pp. 835-843, 2015.
11. J. S. Bakken, T. Borody, L. J.Brandt et al., "Treating clostridium difficile infection with fecal microbiota transplantation," Clinical Gastroenterology and Hepatology, vol. 9, no. 12, pp. 1044-1049, 2011.
12. H. Sokol, T.Galperine,N. Kapel et al., "Faecalmicrobiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of faecal microbiota transplantation," Digestive and Liver Disease, vol. 48, pp. 242-247, 2016.
13. J. Aas, C. E. Gessert, and J. S. Bakken, "Recurrent Clostridium difficile colitis: Case series involving 18 patients treated with donor stool administered via a nasogastric tube," Clinical Infectious Diseases, vol. 36, no. 5, pp. 580-585, 2003.
14. A. Aratari, G. Cammarota, and C. Papi, "Fecal microbiota transplantation for recurrent C. difficile infection in a patient with chronic refractory ulcerative colitis," Journal of Crohn's and Colitis, vol. 9, no. 4, p. 367, 2015.
15. M. Bilal, R. Khehra, C. Strahotin, and R. Mitre, "Long-term follow-up of fecal microbiota transplantation for treatment of recurrent clostridium difficile infection in a dual solid organ transplant recipient," Case Reports in Gastroenterology, vol. 9, pp. 156-159, 2015.
16. L. M. Blackburn, A. Bales, M. Caldwell, L. Cordell, S. Hamilton, and H. Kreider, "Fecal microbiota transplantation in patients with cancer undergoing treatment," Clinical Journal of Oncology Nursing, vol. 19, no. 1, pp. 111-114, 2015.
17. C. G. de Castro, A. J. Ganc, R. L. Ganc, M. S. Petrolli, and N. Hamerschlack, "Fecal microbiota transplant after hematopoietic SCT: Report of a successful case," Bone Marrow Transplantation, vol. 50, no. 1, p. 145, 2015.
18. C. A. Duplessis, D. You, M. Johnson, and A. Speziale, "Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection," Infection, vol. 40, no. 4, pp. 469-472, 2012.
19. P. Ehlermann, A. O. Dosch, and H. A. Katus, "Donor fecal transfer for recurrent Clostridium difficile-associated diarrhea in heart transplantation," The Journal of Heart and Lung Transplantation, vol. 33, no. 5, pp. 551-553, 2014.
20. L. Elopre and M. Rodriguez, "Fecal microbiota therapy for recurrent Clostridium difficile infection in HIV-infected persons," Annals of Internal Medicine, vol. 158, no. 10, pp. 779-780, 2013.
21. M. Fischer, D. Kao, C. Kelly et al., "Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory BowelDisease," Inflammatory Bowel Diseases, vol. 22,no. 10,pp. 2402-2409, 2016.
22. R. J. Friedman-Moraco, A. K. Mehta, G. M. Lyon, and C. S. Kraft, "Fecalmicrobiota transplantation for refractoryClostridium difficile colitis in solid organ transplant recipients," American Journal of Transplantation, vol. 14, no. 2, pp. 477-480, 2014.
23. K. Garborg, B. Waagsbø, A. Stallemo, J. Matre, and A. Sundøy, "Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea," Infectious Diseases, vol. 42, no. 11-12, pp. 857-861, 2010.
24. J. C. Gathe, E. M. Diejomaoh, C. C. Mayberry, and J. B. Clemmons, "Fecal Transplantation for Clostridium Difficile-"all Stool May Not Be Created Equal"," Journal of the International Association of Providers of AIDS Care, vol. 15, no. 2, pp. 107-108, 2016.
25. E. M. Gutierrez-Delgado, E. Garza-Gonzalez,M. A. Martinez-Vazquez et al., "Fecal transplant for Clostridium difficile infection relapses using "pooled" frozen feces from non-related donors,"Acta Gastro-Enterologica Belgica, vol. 79, no. 2, pp. 268-270, 2016.
26. T.-G.Gweon, K. J. Lee,D. Kang et al., "Acase of toxicmegacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation," Gut and Liver, vol. 9, no. 2,pp. 247-250, 2015.
27. B.E. Hirsch,N.Saraiya, K. Poeth,R.M.Schwartz,M. E. Epstein, and G. Honig, "Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection," BMC Infectious Diseases, vol. 15, p. 191, 2015.
28. S. K. Hourigan, L. A. Chen, Z. Grigoryan et al., "Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease," Alimentary Pharmacology &Therapeutics, vol. 42, no. 6, pp. 741-752, 2015.
29. C. R. Kelly, C. Ihunnah, M. Fischer et al., "Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients," American Journal of Gastroenterology, vol. 109, no. 7, pp. 1065-1071, 2014.
30. A. Khoruts, K. M. Rank, K. M. Newman et al., "Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection," Clinical Gastroenterology and Hepatology, vol. 14, no. 10, pp. 1433-1438, 2016.
31. M. P. Kronman, H. J. Nielson, A. L. Adler et al., "Fecal microbiota transplantation via nasogastric tube for recurrent clostridium difficile infection in pediatric patients," Journal of Pediatric Gastroenterology and Nutrition, vol. 60, no. 1, pp. 23-26, 2015.
32. M. Laszlo, L. Ciobanu,V. Andreica, andO. Pascu, "Fecal transplantation indications in ulcerative colitis. preliminary study," Clujul Medical, vol. 89, no. 2, pp. 224-228, 2016.
33. C. H. Lee, J. E. Belanger, Z. Kassam et al., "The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecalmicrobiota transplantation via retention enema," European Journal of ClinicalMicrobiology&InfectiousDiseases, vol. 33, no. 8, pp. 1425-1428, 2014.
34. T. J. Lee and C. M. Jones, "A report of fecal transplantation for refractory clostridium difficile colitis in an orthotopic liver transplant recipient," Journal of Gastroenterology and Hepatology Research, vol. 3, no. 11, pp. 1357-1359, 2014.
35. P. Loke, R. G. Heine, V. McWilliam, D. J. S. Cameron, M. L. K. Tang, and K. J. Allen, "Fecal microbial transplantation in a pediatric case of recurrent Clostridium difficile infection and specific antibody deficiency," Pediatric Allergy and Immunology, vol. 27, no. 8, pp. 872-874, 2016.
36. A.Mandalia,A.Ward,W.Tauxe, C. S.Kraft, andT. Dhere, "Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile," International Journal of Colorectal Disease, vol. 31, no. 5, pp. 1059-1060, 2016.
37. E. Mattila, R. Uusitalo-Seppala, M.Wuorela et al., "Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection," Gastroenterology, vol. 142, no. 3, pp. 490-496, 2012.
38. C. Mittal, N. Miller, A. Meighani, B. R. Hart, A. John, and M. Ramesh, "Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma," Bone Marrow Transplantation, vol. 50, no. 7, p. 1010, 2015.
39. K. Neemann, D. D. D. Eichele, P. P. W. Smith, R. Bociek, M. Akhtari, and A. Freifeld, "Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient," Transplant Infectious Disease, vol. 14, no. 6, pp. E161-E165, 2012.
40. S. J. Ott, G. H. Waetzig, A. Rehman et al., "Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection," Gastroenterology, vol. 152, no. 4, pp. 799-811, 2017.
41. R. Pathak,H. A. Enuh,A. Patel,andP.Wickremesinghe, "Treatment of relapsing clostridium difficile infection using fecal microbiota transplantation," Clinical and Experimental Gastroenterology, vol. 7, pp. 1-6, 2013.
42. A. Pierog, A. Mencin, andN. R. Reilly, "Fecalmicrobiota transplantation in children with recurrent clostridium difficile infection," The Pediatric Infectious Disease Journal, vol. 33, no. 11, pp. 1198-1200, 2014.
43. R. J. Porter, "Pulsed faecal microbiota transplantation for recalcitrant recurrent Clostridium difficile infection," Clinical Microbiology and Infection, vol. 21, no. 3, pp. e23-e24, 2015.
44. R. Quera, R. Espinoza, C. Estay, and D. Rivera, "Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection," Journal of Crohn's and Colitis, vol. 8, no. 3, pp. 252-253, 2014.
45. F. H. Ramay, A. Amoroso, E. C. Von Rosenvinge, and K. Saharia, "Fecal microbiota transplantation for treatment of severe, recurrent, and refractory clostridium difficile infection in a severely immunocompromised patient," Infectious Diseases in Clinical Practice, vol. 24, no. 4, pp. 237-240, 2016.
46. A. Ray, R. Smith, and J. Breaux, "Fecal microbiota transplantation for clostridium difficile infection:The ochsner experience," The Ochsner Journal, vol. 14, no. 4, pp. 538-544, 2014.
47. T. A. Rubin, C. E. Gessert, J. Aas, and J. S. Bakken, "Fecal microbiome transplantation for recurrent Clostridium difficile infection: Report on a case series," Anaerobe, vol. 19, no. 1, pp. 22-26, 2013.
48. G. H. Russell, J. L. Kaplan, I. Youngster et al., "Fecal transplant for recurrent clostridium difficile infection in children with and without inflammatory bowel disease," Journal of Pediatric Gastroenterology and Nutrition, vol. 58, no. 5,pp. 588-592, 2014.
49. M. Schunemann and M. Oette, "Fecal microbiota transplantation for Clostridium difficile-associated colitis in a severely immunocompromized critically ill AIDS patient: A case report," AIDS, vol. 28, no. 5, pp. 798-799, 2014.
50. M. S. Silverman, I. Davis, and D. R. Pillai, "Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection," Clinical Gastroenterology and Hepatology, vol. 8, no. 5, pp. 471-473, 2010.
51. J. Stripling, R. Kumar, J.W. Baddley et al., "Loss of vancomycinresistant enterococcus fecal dominance in an organ transplant patient with clostridium difficile colitis after fecal microbiota transplant," Open Forum Infectious Diseases, vol. 2, no. 2, 2015.
52. J. A. Trubiano, A. George, J. Barnett et al., "A different kind of "allogeneic transplant": Successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma," Leukemia &Lymphoma, vol. 56, no. 2, pp. 512-514, 2015.
53. B. J. Webb, A. Brunner, C. D. Ford, M. A. Gazdik, F. B. Petersen, and D. Hoda, "Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients," Transplant Infectious Disease, vol. 18, no. 4, pp. 628-633, 2016.
54. A. R.Weingarden, M. J.Hamilton,M. J. Sadowsky, andA. Khoruts, "Resolution of severe clostridium difficile infection following sequential fecal microbiota transplantation," Journal of Clinical Gastroenterology, vol. 47, no. 8, pp. 735-737, 2013.
55. S. S. Yoon and L. J. Brandt, "Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: A case series of 12 patients," Journal of Clinical Gastroenterology, vol. 44, no. 8, pp. 562-566, 2010.
56. H. Zainah and A. Silverman, "Fecal bacteriotherapy: A case report in an immunosuppressed patient with ulcerative colitis and recurrent,"Case Reports in Infectious Diseases, vol. 2012,Article ID 810943, 2 pages, 2012.
57. "StudyQuality Assessment tools," in Quality Assessment Tool for Case series Studies, National Heart, Lung, and Blood institute, https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
58. G. Ianiro, M. Maida, J. Burisch et al., "Efficiacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis," United European Gastroenterology Journal, pp. 1-13, 2018.
59. L. J. Brandt, O. C. Aroniadis, M. Mellow et al., "Long-term follow-up of colonoscopic fecalmicrobiota transplant for recurrent Clostridium difficile infection," American Journal of Gastroenterology, vol. 107, no. 7, pp. 1079-1087, 2012.
60. A. Bafeta, A. Yavchitz, C. Riveros, R. Batista, and P. Ravaud, "Methods and reporting studies assessing fecal microbiota transplantation: A systematic review," Annals of Internal Medicine, vol. 167, no. 1, pp. 34-39, 2017.
61. C.H. Lee, T. Steiner, E.O. Petrof et al., "Frozen vs fresh fecalmicrobiota transplantation and clinical resolution of diarrhea in patientswith recurrent clostridiumdifficile infection a randomized clinical trial," Journal of the AmericanMedical Association, vol. 315, no. 2, pp. 142-149, 2016.